Contracts › 75F40126F19012
75F40126F19012: Drug Labeling Initiative - Cder Support
Awarded to Deloitte Consulting Llp by Food and Drug Administration (FDA).
$5.7Mobligated
$5.7Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126F19012 |
|---|---|
| Vehicle | 75F40122A00018 |
| Awardee | Deloitte Consulting Llp |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 All Other Professional, Scientific, and Technical Services |
| PSC | B528 Special Studies/Analysis- Regulatory |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 30 September 2026 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541990 contracts · All expiring contracts · USASpending record